Health
Novel prostate cancer resistance mechanism could be a promising target – Drug Target Review
By inhibiting the activity of microRNA-194 (miR-194), scientists prevented prostate cancer cells from developing treatment resistance.
Posted: 6 January 2021 | Hannah Balfour (Drug Target Review) | No comments yet
By inhibiting the activity of microRNA-194 (miR-194), scientists prevented prostate cancer cells from developing treatment resistance in vitro.
Researchers have identified a new mechanism through which prostate cancer cells convert to a more aggressive subtype in response to hormonal therapies. According to the team, further exploration of their findings may enable scientists to develop more targeted ways to remedy treatment…
-
Noosa News19 hours agoChild, 15, arrested over death of another child, 8, after shocking e-bike crash in Queensland
-
Noosa News17 hours agoDeath of German shepherd Arnie prompts Brisbane community action to protect pets caught up in crime
-
General13 hours agoPerth man charged after investigation into organised crime and tobacco store attacks
-
General17 hours agoCrowe toasts talkback titan for platforming ‘voiceless’